Patient-Helpdesk.com

gist patient assistance

by Mr. Dexter Murazik Published 2 years ago Updated 1 year ago
image

Patient Assistance Programs for GIST-approved Medications

  • Gleevec (Novartis) Novartis offers help to patients who are experiencing financial hardship or who have limited or no third-party insurance coverage for their medicines. ...
  • Sutent (Pfizer) Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. ...
  • Stivarga (Bayer) ...
  • Ayvakit (Blueprint Medicines) ...

Patient Access Network Foundation is dedicated to assisting patients who cannot afford the out-of-pocket costs associated with their treatment needs. With disease-specific funds, PAN assists the underinsured in accessing health care treatments. More information is available on the website or call 1-866-316-7263.May 9, 2022

Full Answer

What is the best treatment for gist cancer?

Types of treatment for GIST include:

  • Surgery for Gastrointestinal Stromal Tumors
  • Targeted Drug Therapy for Gastrointestinal Stromal Tumors
  • Ablation and Embolization to Treat Gastrointestinal Stromal Tumors
  • Chemotherapy for Gastrointestinal Stromal Tumors
  • Radiation Therapy for Gastrointestinal Stromal Tumors

What is the prognosis for gist?

The overall relative 5-year survival rate for GIST is 83 percent, but this varies by stage and other factors. Newer therapies offer a more personalized approach to treatment, which may affect...

What is the prognosis of a GIST tumor?

  • Those with localized GIST tumors had a 5-year survival rate of 93%.
  • Those with regional GIST tumors which spread to nearby tissues had a 5-year survival rate of 80%.
  • Those with distant GIST tumors, which have metastasized to other body parts, had a 5-year survival rate of 55%.

Is Gist malignant or benign?

They are known as extra gastrointestinal stromal tumours. GISTs can either be benign, meaning it is not cancerous, or malignant. Malignant cancer cells are harmful because they have greater uncontrollable growth and can spread throughout the body. CLICK HERE TO SEE AVAILABLE TRIALS.

What is the purpose of the GIST fund?

Is GIST a rare sarcoma?

image

What type of tumor is GIST?

A gastrointestinal stromal tumor (GIST) is a type of cancer that begins in the digestive system. GIST s happen most often in the stomach and small intestine. A GIST is a growth of cells that's thought to form from a special type of nerve cells. These special nerve cells are in the walls of the digestive organs.

Can metastatic GIST be cured?

Although TKI therapies have revolutionized the treatment of recurrent or metastatic GISTs, they cannot cure GISTs.

Can you live a long life with GIST?

Summary: Nearly one in four patients with incurable gastrointestinal stromal tumors (GIST) treated with Gleevec will survive 10 years, a new report outlines.

How long can you live with GIST?

5-year relative survival rates for GISTSEER Stage5-Year Relative Survival RateLocalized93%Regional81%Distant53%All SEER stages combined83%Feb 28, 2022

How long can you live with metastatic GIST?

Results: One-hundred and fifteen patients with metastatic GIST were included in the final study cohort. Median overall survival (OS) was 6.9 years (95% CI 5.6–8.3).

Can GIST be completely cured?

Resectable gastrointestinal stromal tumors (GISTs) can be completely or almost completely removed by surgery. Treatment may include the following: Surgery to remove tumors that are 2 centimeters or larger. Laparoscopic surgery may be done if the tumor is 5 cm or smaller.

Can you survive stage 4 GIST?

Overall, 88% of patients with stage 4 gastrointestinal stromal tumors were alive at one year, 77% were alive at two years, 67% were alive at three years and 51% were alive at five years.

What is a metastatic GIST?

Metastatic GIST is a type of cancer that starts in the gastrointestinal (GI) tract and spreads to distant tissues or organs. Traditional chemotherapy and radiation aren't usually effective in treating GISTs. New targeted biologic therapies provide more promising treatment options for people with advanced GIST.

How to contact Novartis patient assistance?from liferaftgroup.org

To access these resources, visit https://www.pharma.us.novartis.com/our-products/patient-assistance/ or call 1-800-282-7630 for information on Novartis Patient Assistance or other resources available for eligible patients.

What is the Patient Access Network Foundation?from liferaftgroup.org

Patient Access Network Foundation is dedicated to assisting patients who cannot afford the out-of-pocket costs associated with their treatment needs. With disease-specific funds, PAN assists the underinsured in accessing health care treatments. Call 1-866-316-7263 for visit https://panfoundation.org/.

What is Reach for Stivarga?from liferaftgroup.org

REACH patients prescribed Stivarga can turn to REACH® (Resources for Expert Assistance and Care Helpline) – a free support program providing you with information about your therapy as well as your financial assistance options. https://www.stivarga-us.com/getting-and-paying/

What is the Cancer Society Road to Recovery Program?from liferaftgroup.org

Cancer Society Road to Recovery Program offers a directory of available options, sorted by city. The ACS Road to Recovery program partners with municipalities, faith-based organizations, and a network of volunteer drivers to provide the much-needed rides back and forth to appointments. More information on the program is available at https://www.cancer.org/treatment/support-programs-and-services.html or by calling 1-800-227-2345.

What is the PAF program?from liferaftgroup.org

Patient Advocate Foundation (PAF) provides co-pay assistance for patients with Metastatic Gastric Cancer. Information about the PAF Co-Pay Relief Program can be obtained by calling 1-866-512-3861, option1, or visiting www.copays.org or www.patientadvocate.org.

What is Partnership for Prescription Assistance?from liferaftgroup.org

Partnership for Prescription Assistance helps qualifying patients who lack prescription coverage get the medicines they need for free or nearly free.

What age does Benefits Checkup pay for?from liferaftgroup.org

Benefits Checkup finds programs for people ages 55 and over that may pay for some of their costs of prescription drugs, health care, utilities, and other services.

How to contact Novartis patient assistance?

To access these resources, visit https://www.pharma.us.novartis.com/our-products/patient-assistance/ or call 1-800-282-7630 for information on Novartis Patient Assistance or other resources available for eligible patients.

What is Pfizer compassionate use?

Such individual use of an unlicensed investigational drug is often called “compassionate use” or “expanded access”, but may go by other names. Pfizer refers to these uses collectively as “compassionate access”.

What is Reach for Stivarga?

REACH patients prescribed Stivarga can turn to REACH® (Resources for Expert Assistance and Care Helpline) – a free support program providing you with information about your therapy as well as your financial assistance options. https://www.stivarga-us.com/getting-and-paying/

What age does Benefits Checkup pay for?

Benefits Checkup finds programs for people ages 55 and over that may pay for some of their costs of prescription drugs, health care, utilities, and other services.

Does Novartis offer financial assistance?

Novartis offers help to patients who are experiencing financial hardship or who have limited or no third-party insurance coverage for their medicines. Patient Assistance Now is a website designed for patients to find financial assistance programs for their Novartis Medications. Patient Assistance Foundation Enrollment offers help to patients who are experiencing financial hardship or who have limited or no third-party insurance coverage for their medicines.

Can a physician submit compassionate use?

Treating physicians may submit compassionate use or expanded access requests on behalf of patients or their caregivers. Patients or non-healthcare professionals may not submit requests, but may gain information and submit questions by visiting https://www.pfizer.com/purpose/medicine-access/compassionate-use/. Physicians may submit requests to Pfizer at PfizerCAReS.com.

What is a gastrointestinal stromal tumor patient support group?

Our gastrointestinal stromal tumor patient support group provides a safe space to connect with others coping with gastrointestinal stromal tumor and is led by an oncology social worker who provides emotional and practical support.

How long is the stromal support group?

Connect with others in our free, 15-week online support group for people diagnosed with a gastrointestinal stromal tumor who are currently receiving treatment. In this group led by an oncology social worker, members can share their personal experiences, ways of coping and helpful resources.

How to diagnose a GIST?

GIST is most commonly diagnosed by pathological analysis of biopsy tissue taken during an endoscopy or through the skin. Computed tomography (CT) and magnetic resonance (MR) imaging are also used to diagnose GIST and determine the location and extent of the tumor.

What is the FDA approved treatment for GIST?

In 2006, another tyrosine kinase inhibitor, Sutent (sunitinib), was approved by the FDA for the treatment of GIST in individuals in whom the disease had progressed, despite therapy with Gleevec, or in patients who cannot take Gleevec. In 2013, a third type of tyrosine kinase inhibitor known as Stivarga (regorafenib) was approved by the FDA for the treatment of GIST, specifically for individuals with advanced GIST that cannot be treated surgically and who no longer respond to other FDA-approved treatments (i.e., Gleevec and Sutent). Stivarga inhibits that activity of numerous tyrosine kinases that promote cancer growth. In 2018, the FDA approved larotrectinib, also a tyrosine kinase inhibitor, for the treatment of any tumor bearing a fusion of the NTRK3 gene (not only in GIST). This was only the second drug to be approved for treatment of cancers with a specific mutation, regardless of tissue type, underscoring the importance of categorizing GISTs by their specific biology.

What is the cause of GIST?

Most GISTs result from a non-inherited change (mutation) in one of two genes, KIT or PDGFRA, which leads to inappropriate and ongoing division of tumor cells. However, approximately 10%–15% of cases of GIST in adults and 85% of cases in children are not associated with mutations in either the KIT or PDGFRA genes.

How to treat a GIST tumor?

Surgical removal is the most common treatment for GIST that has not spread, and an operation provides the best chance of a cure if the tumor is completely removed. In cases where the tumor has spread, oral chemotherapy (i.e., pills) is usually indicated in conjunction with surgery. The most frequently used drugs are tyrosine kinase inhibitors (e.g., Gleevec), which target the commonly observed mutations in KIT and PDFGRA. Patients respond differently to the range of available tyrosine kinase inhibitors, so it can be useful to test for specific mutations in the tumor when selecting a course of therapy. Clinical trials are also underway to target subtypes of GIST with rare genetic abnormalities. Finally, it is noteworthy that there is no role for radiation therapy in the management of GIST.

What are the symptoms of a GIST?

Signs & Symptoms. GIST can present with a wide spectrum of subjective symptoms, such as nausea, early satiety, bloating, and weight loss. Patients can also experience objective signs of a tumor, such as anemia (low red blood cell count) or a lump in the abdomen.

What are some alternative approaches to surgery and chemotherapy?

Alternative approaches to surgery and chemotherapy include treatments directed at sites of liver involvement. Bland, radio-, or chemo-embolization are ways of decreasing blood supply to the tumor sites within the liver and can control disease for some time. Another approach, called microwave ablation, uses localized microwaves to burn tumors in the liver.

What is the most common site of spread for a tumor?

Most patients undergo a computed tomography ( CT) or magnetic resonance imaging ( MRI) scan to determine the extent of the tumor involved. It is most important to image the abdomen and pelvis, as the most common sites of spread are within the abdominal cavity and the liver. PET/CT scanning may be helpful as an additional test in cases where there is diagnostic uncertainty; however, it is not routinely performed.

How to contact Novartis patient assistance?from liferaftgroup.org

To access these resources, visit https://www.pharma.us.novartis.com/our-products/patient-assistance/ or call 1-800-282-7630 for information on Novartis Patient Assistance or other resources available for eligible patients.

What is the Patient Access Network Foundation?from liferaftgroup.org

Patient Access Network Foundation is dedicated to assisting patients who cannot afford the out-of-pocket costs associated with their treatment needs. With disease-specific funds, PAN assists the underinsured in accessing health care treatments. Call 1-866-316-7263 for visit https://panfoundation.org/.

What is Reach for Stivarga?from liferaftgroup.org

REACH patients prescribed Stivarga can turn to REACH® (Resources for Expert Assistance and Care Helpline) – a free support program providing you with information about your therapy as well as your financial assistance options. https://www.stivarga-us.com/getting-and-paying/

What is the Cancer Society Road to Recovery Program?from liferaftgroup.org

Cancer Society Road to Recovery Program offers a directory of available options, sorted by city. The ACS Road to Recovery program partners with municipalities, faith-based organizations, and a network of volunteer drivers to provide the much-needed rides back and forth to appointments. More information on the program is available at https://www.cancer.org/treatment/support-programs-and-services.html or by calling 1-800-227-2345.

What is the PAF program?from liferaftgroup.org

Patient Advocate Foundation (PAF) provides co-pay assistance for patients with Metastatic Gastric Cancer. Information about the PAF Co-Pay Relief Program can be obtained by calling 1-866-512-3861, option1, or visiting www.copays.org or www.patientadvocate.org.

What is Partnership for Prescription Assistance?from liferaftgroup.org

Partnership for Prescription Assistance helps qualifying patients who lack prescription coverage get the medicines they need for free or nearly free.

What age does Benefits Checkup pay for?from liferaftgroup.org

Benefits Checkup finds programs for people ages 55 and over that may pay for some of their costs of prescription drugs, health care, utilities, and other services.

What is a Kit+ gastrointestinal stromal tumor?from drugs.com

KIT+ gastrointestinal stromal tumors (GISTs) are soft tissue sarcomas ( cancers that begin in the bones and the soft tissues ).

How should I take Gleevec?from drugs.com

Take Gleevec exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets.

Can you eat grapefruit juice while taking a med?from webmd.com

Avoid eating grapefruit or drink ing grapefruit juice while using this medication unless your doctor or pharmacist says you may do so safely. Grapefruit can increase the chance of side effects with this medicine. Ask your doctor or pharmacist for more details.

What to tell your healthcare provider before taking ayvakit?

Before taking AYVAKIT, tell your healthcare provider about all of your medical conditions, including if you: have low platelet counts. have bulging or weakening of a blood vessel wall (aneurysm) or history of bleeding in your brain. have a history of stroke within the last year. are pregnant or plan to become pregnant.

What to do if you have questions about your treatment?

Talk to your doctor if you have questions about your treatment.

What is AYVAKIT treatment?

AYVAKIT is a treatment for adults with advanced systemic mastocytosis.

What is the purpose of the GIST fund?

The purpose of this fund is to provide financial assistance for needy GIST patients/guardians to seek a second opinion from a GIST specialist for the management and treatment of GIST.

Is GIST a rare sarcoma?

Because GIST is a very rare sarcoma, it is sometimes necessary for the patient to travel to a sarcoma expert for a second opinion or treatment. Realizing the importance of getting patients the best care possible, GIST Support International offers a one-time grant to those who need financial help with expenses that are not reimbursed for this travel and treatment. Because the funding for this program is limited, this program will not be open to every GISTer, but only to those who truly need it.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9